- Lactic acid oligomers (OLAs) as prodrug moieties.
Lactic acid oligomers (OLAs) as prodrug moieties.
Die Pharmazie (2013-03-09)
J Kruse, B Lachmann, R Lauer, S Eppacher, C R Noe
PMID23469680
要旨
In this paper we propose the use of lactic acid oligomers (OLAs) as prodrug moieties. Two synthetic approaches are presented, on the one hand a non selective oligomerisation of lactic acid and on the other hand a block synthesis to tetramers of lactic acid. Dimers of lactic acid were investigated with respect to their plasma stability and their adsorption to albumine. Ibuprofen was chosen as the first drug for OLAylation. The ester 19 of LA(1)-ibuprofen was evaluated with respect to the degradation to human plasma and the adsorption to albumine. All results indicate that lactic acid oligomers are promising prodrug moieties.
材料
製品番号
ブランド
製品内容
Supelco
イブプロフェン 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
イブプロフェン, European Pharmacopoeia (EP) Reference Standard
イブプロフェン, European Pharmacopoeia (EP) Reference Standard